Top compounds associated with response to CTD-2021K4.1


Feature Type Standardized
Nominal ANOVA
mRNA CR-1-31B CTRPv2 pan-cancer AAC 0.06 0.08
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.058 0.08
mRNA necrostatin-7 CTRPv2 pan-cancer AAC -0.068 0.08
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.08
mRNA SKI-II CTRPv2 pan-cancer AAC 0.07 0.08
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.08
mRNA decitabine CTRPv2 pan-cancer AAC 0.049 0.09
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.07 0.09
mRNA A-804598 CTRPv2 pan-cancer AAC -0.085 0.09
mRNA niclosamide CTRPv2 pan-cancer AAC 0.063 0.09
Download CSV